Found: 23
Select item for more details and to access through your institution.
Medications That Prolong the QT Interval—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 8, p. 1025, doi. 10.1001/jama.290.8.1025-a
- By:
- Publication type:
- Article
What Clinicians Should Know About the QT Interval.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 16, p. 2120, doi. 10.1001/jama.289.16.2120
- By:
- Publication type:
- Article
Using Central IRBs for Multicenter Clinical Trials in the United States.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054999
- By:
- Publication type:
- Article
New Antiarrhythmic Agents for Atrial Fibrillation and Atrial Flutter: United States Drug Market Response as an Indicator of Acceptance.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1316, doi. 10.1592/phco.23.12.1316.32703
- By:
- Publication type:
- Article
A survey of health care practitioners' knowledge of the QT interval.
- Published in:
- 2005
- By:
- Publication type:
- journal article
International variation in the use of evidence-based medicines for acute coronary syndromes.
- Published in:
- European Heart Journal, 2003, v. 24, n. 23, p. 2133, doi. 10.1016/j.ehj.2003.09.018
- By:
- Publication type:
- Article
Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 301, n. 8, p. 831, doi. 10.1001/jama.2009.205
- By:
- Publication type:
- Article
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 2, p. 159, doi. 10.1001/jama.297.2.joc60179
- By:
- Publication type:
- Article
Case reports of heart failure after therapy with a tumor necrosis factor antagonist.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 12, p. 1350, doi. 10.1002/pds.3321
- By:
- Publication type:
- Article
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 12, p. 1226, doi. 10.1002/pds.1675
- By:
- Publication type:
- Article
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 8, p. 782, doi. 10.1002/pds.1617
- By:
- Publication type:
- Article
Frequency of high-risk use of QT-prolonging medications.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 6, p. 361, doi. 10.1002/pds.1155
- By:
- Publication type:
- Article
Managing the risks of therapeutic products: proceedings of a workshop.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2005, v. 14, n. 9, p. 619, doi. 10.1002/pds.1060
- By:
- Publication type:
- Article
Knowledge deficits related to the QT interval could affect patient safety.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Knowledge Deficits Related to the QT Interval Could Affect Patient Safety.
- Published in:
- Annals of Noninvasive Electrocardiology, 2003, v. 8, n. 2, p. 157, doi. 10.1046/j.1542-474X.2003.08211.x
- By:
- Publication type:
- Article
Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 17, p. 1838, doi. 10.1001/jama.2012.3424
- By:
- Publication type:
- Article
Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change.
- Published in:
- Annals of Internal Medicine, 2009, v. 151, n. 3, p. 206, doi. 10.7326/0003-4819-151-3-200908040-00126
- By:
- Publication type:
- Article
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure
- Published in:
- 2002
- By:
- Publication type:
- journal article
Participants’ perspectives on safety monitoring in clinical trials.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Participants’ perspectives on safety monitoring in clinical trials.
- Published in:
- Clinical Trials, 2013, v. 10, n. 4, p. 552, doi. 10.1177/1740774513484394
- By:
- Publication type:
- Article
Use of central institutional review boards for multicenter clinical trials in the United States: A review of the literature.
- Published in:
- Clinical Trials, 2013, v. 10, n. 4, p. 560, doi. 10.1177/1740774513484393
- By:
- Publication type:
- Article
Monitoring the quality of conduct of clinical trials: a survey of current practices.
- Published in:
- Clinical Trials, 2011, v. 8, n. 3, p. 342, doi. 10.1177/1740774511402703
- By:
- Publication type:
- Article